Genvor Incorporated is a developer of sustainable plant health solutions, with a portfolio of patented peptides to provide crops with anti-pathogen and enhanced nutritional properties through biological foliar application as well as transgenic seed traits. The Company’s proprietary BioCypher Algorithm combines computational biology, machine learning, and regulatory benchmarks to create peptides that optimize agricultural outcomes with biological safety. With multiple patents and proprietary peptides in active development, it offers ready-to-deploy licensing opportunities that integrate with existing production infrastructure and regulatory frameworks. The Company’s platform centers on the development of anti-microbial peptides (AMPs), which are designed to combat a broad spectrum of debilitating and destructive plant diseases including bacterial, fungal, and viral pathogens that threaten crop productivity worldwide.